Noah Hahn

Financial relationships

  • Attribution: 
    Self
    Type of financial relationship: 
    Independent contractor
    Ineligible company: 
    Janssen
    Mitigation strategy: 
    Peer review
    Date reviewed: 
    08/31/2022
  • Attribution: 
    Self
    Type of financial relationship: 
    Independent contractor
    Ineligible company: 
    Health Advances
    Mitigation strategy: 
    Peer review
    Date reviewed: 
    08/31/2022
  • Attribution: 
    Self
    Type of financial relationship: 
    Employment
    Ineligible company: 
    TransMed
    Mitigation strategy: 
    Peer review
    Date reviewed: 
    08/31/2022
  • Attribution: 
    Self
    Type of financial relationship: 
    Independent contractor
    Ineligible company: 
    Incyte
    Mitigation strategy: 
    Peer review
    Date reviewed: 
    08/31/2022
  • Attribution: 
    Self
    Type of financial relationship: 
    Other
    Ineligible company: 
    Inovio
    Mitigation strategy: 
    Peer review
    Date reviewed: 
    08/31/2022
  • Attribution: 
    Self
    Type of financial relationship: 
    Independent contractor
    Ineligible company: 
    Seattle Genetics
    Mitigation strategy: 
    Peer review
    Date reviewed: 
    08/31/2022
  • Attribution: 
    Self
    Type of financial relationship: 
    Other
    Ineligible company: 
    Genentech
    Mitigation strategy: 
    Peer review
    Date reviewed: 
    08/31/2022
  • Attribution: 
    Self
    Type of financial relationship: 
    Other
    Ineligible company: 
    AstraZeneca
    Mitigation strategy: 
    Peer review
    Date reviewed: 
    08/31/2022
  • Attribution: 
    Self
    Type of financial relationship: 
    Independent contractor
    Ineligible company: 
    Principia
    Mitigation strategy: 
    Peer review
    Date reviewed: 
    08/31/2022
  • Attribution: 
    Self
    Type of financial relationship: 
    Independent contractor
    Ineligible company: 
    Pieris
    Mitigation strategy: 
    Peer review
    Date reviewed: 
    08/31/2022

Pages

Return to Update Series (2022) Lesson 29: Systemic Therapy for Bladder Cancer: Implications for the Urologist